Quantitative brain MRI was used to evaluate 18 RRMS patients and 10 age matched controls at baseline and 6 months. The study aimed to assess test-retest reproducibility in healthy controls, disease variability in the RRMS population, and sensitivity to disease progression of each MRI-derived parameter. The results will inform the selection of MRI measures to be used as biomarkers in future clinical trials. In addition, longitudinal multiparametric assessment of MS lesions may improve our understanding of different pathological components of such lesions (e.g. inflammation, demyelination, and iron accumulation) during disease progression.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords